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Abstract
The nematode Caenorhabditis elegans offers currently untapped potential for carrying out high-throughput, live-animal
screens of low molecular weight compound libraries to identify molecules that target a variety of cellular processes. We
previously used a bacterial infection assay in C. elegans to identify 119 compounds that affect host-microbe interactions
among 37,214 tested. Here we show that one of these small molecules, RPW-24, protects C. elegans from bacterial infection
by stimulating the host immune response of the nematode. Using transcriptome profiling, epistasis pathway analyses with
C. elegans mutants, and an RNAi screen, we show that RPW-24 promotes resistance to Pseudomonas aeruginosa infection by
inducing the transcription of a remarkably small number of C. elegans genes (,1.3% of all genes) in a manner that partially
depends on the evolutionarily-conserved p38 MAP kinase pathway and the transcription factor ATF-7. These data show that
the immunostimulatory activity of RPW-24 is required for its efficacy and define a novel C. elegans–based strategy to identify
compounds with activity against antibiotic-resistant bacterial pathogens.
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Introduction
Studies in the model nematode Caenorhabditis elegans have greatly
expanded our understanding of development, neurobiology, host-
pathogen interactions, and many other aspects of metazoan
biology. Here we show that C. elegans-based assays enable the
identification of immunostimulatory compounds, which can be
employed together with genetic analyses to interrogate innate
immune signaling pathways.
Previously, we demonstrated that C. elegans can be used in
bacterial infection assays to identify novel antimicrobials [1–3].
Fifteen to twenty C. elegans animals fit comfortably in the wells of
standard 384-well assay plates and the assay can be automated
using image analysis software, which enables such studies to be
conducted in high-throughput [1]. Using this system, we tested
37,214 compounds and identified 119 small molecules that
prolonged the lifespan of nematodes infected with the Gram-
positive human bacterial pathogen Enterococcus faecalis [1].
We hypothesized that the C. elegans-based screen for novel anti-
infectives would identify small molecules that cure nematodes by
stimulating the host innate immune response, in addition to
compounds that block microbial virulence or directly inhibit
bacterial growth [1]. In nature, nematodes consume bacteria for
food and have evolved sophisticated innate immune mechanisms
within their intestinal epithelium to defend against ingested
pathogens [4]. C. elegans mount specific immune responses toward
both bacterial and fungal pathogens using immune signaling
mediators that are strongly conserved throughout evolution [5–
10]. Principal among these regulators is the NSY-1/SEK-1/PMK-
1 Mitogen Activated Protein (MAP) kinase pathway, orthologous
to the ASK1 (MAP kinase kinase kinase)/MKK3/6 (MAP kinase
kinase)/p38 (MAP kinase) pathway in mammals [10]. In C. elegans,
the p38 MAP kinase pathway acts cell autonomously in the
intestine [11] to coordinate the expression of immune effectors
such as C-type lectins and genes that may encode antimicrobial
peptides [8]. Recently, Shivers et al. found that the transcription
factor ATF-7, an ortholog of mammalian ATF2/ATF7, is
phosphorylated by the p38 MAP kinase PMK-1 and is also
required for defense against ingested bacterial pathogens [12].
I nt h i ss t u d y ,w ed e s c r i b eas m a l lm o l e c u l en a m e dR P W - 2 4t h a t
strongly stimulates the innate immune response of C. elegans in a
manner that confers a survival advantage for nematodes during
bacterial infection. We show that the activity of this compound is
partially dependent on the C. elegans p38 MAP kinase cassette and
ATF-7. These data demonstrate that C. elegans c a nb eu s e di nf a c i l ein
vivo screens to identify compounds with desirable biological activities.
Results
A Compound with Curing Activity in a Live Animal
Infection Model Is Not a Traditional Antibiotic
In a previous study, we screened 37,214 small molecules for
those that prolonged the lifespan of C. elegans infected with the
PLoS Genetics | www.plosgenetics.org 1 June 2012 | Volume 8 | Issue 6 | e1002733Gram-positive bacterial pathogen E. faecalis as a means to identify
novel antimicrobials [1]. Of 119 compounds identified, 31 did not
have any structural relationship to known antimicrobials and ten
of these small molecules were effective against E. faecalis in the C.
elegans infection model at doses that did not inhibit growth of the
pathogen in an in vitro growth assay [1]. In contrast, all currently
available antibiotics interfere with some aspect of bacterial growth
or metabolism. In the C. elegans-based assay, traditional antibiotics,
such as tetracycline, ciprofloxacin, ampicillin, and vancomycin,
cured E. faecalis-infected nematodes only at doses several fold
higher than the in vitro minimum inhibitory concentration (MIC)
for bacterial growth [2]. We therefore hypothesized that a subset
of these 31 small molecules conferred a survival advantage to
infected worms by either stimulating the host immune response of
C. elegans or by interfering with virulence factor production in the
bacteria.
We reasoned that a small molecule, which demonstrated curing
activity against diverse bacteria without directly affecting bacterial
growth, would be a candidate immunostimulator. It would be less
likely for such a compound to be a specific inhibitor of bacterial
virulence determinants given the complex and presumably
pathogen-specific nature of these factors. We therefore screened
the 31 compounds described above that did not have any
structural relationship to known antimicrobials for those that
prolonged the lifespan of nematodes infected with Pseudomonas
aeruginosa, a Gram-negative pathogen, at doses lower than the in
vitro MIC for P. aeruginosa. We found that eight of the 31 small
molecules demonstrated in vivo efficacy against nematodes infected
with P. aeruginosa (Table 1, Figure 1A and Figure S1) at doses
several fold lower than the in vitro MIC for these compounds
against P. aeruginosa. Indeed, four of the tested compounds did not
affect the growth of P. aeruginosa at any concentration tested
(Table 1).
To ask if any of these eight compounds could activate the
transcription of a putative immune effector, we used transgenic C.
elegans animals carrying a transcriptional GFP reporter for the gene
F35E12.5 [13]. F35E12.5 encodes a protein that contains a CUB-
like domain and is involved in the transcriptional response towards
several bacterial pathogens, including P. aeruginosa [8,13,14].
Interestingly, one of the four compounds that exhibited P.
aeruginosa curing activity in the C. elegans infection assay without
affecting growth of the pathogen (RPW-24, Figure 1A) activated
the F35E12.5::GFP reporter in a dose dependent manner
(Figure 1B). We therefore decided to focus on RPW-24 and
explore its mode of action in more detail.
Figure 1. RPW-24 activates F35E12.5::GFP and prolongs the
lifespan of C. elegans infected with P. aeruginosa without affect
growth of the pathogen. (A) The chemical structure of 2-N-(3-chloro-
4-methylphenyl) quinazoline-2,4-diamine, which we have named RPW-
24. (B) Fluorescence microscopy images of GFP expression from C.
elegans acIs101 animals, which express a F35E12.5::GFP transgene,
exposed to the indicated concentration of RPW-24 or DMSO, the
solvent control, for 16 hours at 15uC. Green is GFP expression. (C) P.
aeruginosa infection assay of wild-type nematodes exposed to different
concentrations of RPW-24 compared to DMSO. The lifespan extension
conferred by 70, 35 and 7 mM RPW-24 compared to DMSO treatment is
significant in two biological replicates (P,0.0001). Data at each time
point are the average of three plates per strain, each with
approximately 50 animals per plate (sample sizes are given in Table
S2). Data are representative of two independent experiments. (D) RPW-
24 does not affect the growth of P. aeruginosa in the same media used
for the C. elegans infection assay (slow-kill media). Data are the average
of two biological replicates with error bars representing standard
deviation.
doi:10.1371/journal.pgen.1002733.g001
Author Summary
Infections with antibiotic-resistant bacterial pathogens are
increasing at an alarming rate, and there are very few new
therapies currently being developed. We have identified a
small molecule that protects the nematode C. elegans from
bacterial infection by stimulating the host immune
response, not by directly interfering with bacterial growth,
which is the mechanism employed by all currently
available antibiotics. In this study, we investigate the
mode of action of this small molecule and demonstrate
that it stimulates the expression of immune effector
molecules via evolutionarily conserved immune regulators.
These studies illustrate the potential of targeting host
immunity for the treatment of bacterial infections and the
advantages that C. elegans offers both to identify small
molecules that target key cellular processes and to study
their mechanism of action.
An Immunostimulatory Small Molecule in C. elegans
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infected animals in a dose-dependent manner using an agar-based
assay, the typical way that C. elegans infection assays are carried out
in most laboratories (Figure 1C). C. elegans treated with 7, 35 and
70 mM of RPW-24 (but not 0.7 mM) were significantly resistant to
P. aeruginosa infection compared to animals treated with the solvent
control (DMSO)(Figure 1C). To determine if RPW-24 directly
affects the growth of P. aeruginosa, we monitored in vitro bacterial
growth in the presence 70 mM RPW-24 and DMSO. We
conducted these experiments in the same media used for the
nematode killing assay (Figure 1D) or in standard bacterial culture
media (Luria broth, data not shown), but in the absence of C.
elegans. In both cases, we found that 70 mM RPW-24 did not affect
the growth rate of P. aeruginosa (Figure 1D and data not shown). In
the C. elegans- P. aeruginosa pathogenicity assay, we observed that
the intestines of the DMSO-treated animals were markedly
distended and packed with P. aeruginosa cells 40 hours after
infection (Figure S2), consistent with previous observations [9,15].
In contrast, animals treated with RPW-24 had non-distended
intestines, a morphology that was strikingly different from the
DMSO controls (Figure S2).
In summary, RPW-24 is efficacious against both Gram-positive
[1] and Gram-negative bacteria (Figure 1C) at concentrations that
do not inhibit bacterial growth (Figure 1D, Table 1) and activates
the transcription of a putative immune effector, F35E12.5
(Figure 1B). RPW-24 treatment also dramatically reduced the
intestinal burden of P. aeruginosa 40 hours after infection compared
to DMSO controls (Figure S2). These data suggest that RPW-24
affects the host immune response of C. elegans in a manner that
confers a survival advantage against infection with diverse
bacterial pathogens.
Exposure to RPW-24 Induces Immune Response Genes in
C. elegans
To further study the effects of RPW-24 on C. elegans, we used
Affymetrix whole genome GeneChips to generate transcriptome
profiles of wild-type nematodes following exposure to either
70 mM RPW-24 or the solvent control DMSO in liquid culture
media in the absence of bacterial pathogens for 16 hours at 15uC
(Figure 2A). We found that RPW-24 induced a remarkably robust
transcriptional response that involved only a small fraction
(,1.3%) of the genes of the C. elegans genome (Figure 2A). 269
genes were upregulated three-fold or greater (P,0.025), 125 of
which were induced more than 50-fold during RPW-24 exposure
(Table S1). The most highly upregulated gene was expressed more
than 3500-fold higher in compound-exposed worms. For confir-
mation, we used qRT-PCR to analyze 10 genes that exhibited
varying degrees of induction and expression levels in the
microarray analysis (Figure 2A). We found that the transcriptional
changes observed in the transcriptome profiling analysis directly
correlated with the values obtained by qRT-PCR for all 10 genes
tested (Figure S3). We also observed no difference in C. elegans gene
induction whether the RPW-24 exposure occurred in liquid or on
solid media (Figure S3). Taken together, these data suggest that
RPW-24 strongly induces gene transcription in the absence of
pathogen exposure.
Examination of the 269 genes that were induced greater than
three-fold revealed that RPW-24 causes induction of many genes
previously shown to be involved in the C. elegans transcriptional
response to pathogenic bacteria. We found that 70 of the 269
genes induced greater than 3-fold by RPW-24 were also activated
during infection with P. aeruginosa (a gene set characterized by
Troemel et al. [8])(Figure 2B), which is significantly more than the
3.3 gene overlap expected by chance alone (P,2.7610
216).
Among these induced genes are several gene classes that have been
implicated in antimicrobial defenses, such as CUB-like domain-
containing genes, ShK-like toxins, C-type lectins and small
molecule kinases (Table S1) [8]. This result is particularly
interesting considering that RPW-24 is active against P. aeruginosa
in the worm infection model but does not affect growth of the
pathogen in vitro.
The transcriptome profiling analysis demonstrated that RPW-
24 induces the transcription of putative immune effectors while C.
elegans animals are feeding on Escherichia coli OP50, a relatively
non-pathogenic food source for nematodes. We wondered if
RPW-24 would further enhance the induction of these genes when
C. elegans is infected with a bacterial pathogen that activates
expression of these effectors. We therefore used qRT-PCR to test
the level of induction of ten putative immune effectors (Figure 2A)
during P. aeruginosa infection in the presence and absence of RPW-
24. This panel included five genes that contain a CUB-like domain
(C32H11.1, F35E12.5, F08G5.6, C29F3.7, and K08D8.5), two
ShK-like toxins (F49F1.6 and C14C6.5), one antibacterial
lysozyme (lys-7), one C-type lectin (clec-67) and one metallothio-
nein (mtl-1). Eight of these ten genes were activated by P. aeruginosa
in the absence of RPW-24 (Figure 2C). Interestingly, the induction
levels of five of these eight genes (C32H11.1, F08G5.6, F35E12.5,
C29F3.7, and F49F1.6) were markedly increased in the presence of
both RPW-24 and P. aeruginosa (Figure 2C). RPW-24 also caused
the induction of one gene that was strongly repressed during P.
aeruginosa infection (mtl-1) and another whose transcription was
Table 1. Compounds effective against P. aeruginosa in the C. elegans assay at doses that do not inhibit bacterial growth.
Compound Number Effective concentration (mM) in vitro MIC (mM) F35E12.5::GFP
1 3.3 32 2
3 3.3 .264 2
14 5.1 204 2
16 4.8 .192 2
17 8.1 .325 2
18 1.7 33 2
24 11 .351 ++
31 1.6 266 2
RPW-24 induced F35E12.5::GFP expression and was effective against C. elegans infected with P. aeruginosa without inhibiting growth of the bacteria. See Figure 1A and
Figure S1 for the structures of these compounds. ++ represents strong activation of F35E12.5::GFP. MIC equals minimum inhibitory concentration.
doi:10.1371/journal.pgen.1002733.t001
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change the level of induction for clec-67, C14C6.5 or K08D8.5 in
the presence of P. aeruginosa. Taken together, these data
demonstrate that RPW-24 both enhances the expression of a
subset of putative immune effectors that are normally activated
during P. aeruginosa infection and causes the induction of others
that are not activated by P. aeruginosa. We do not, however, think
that the induction of any single gene is itself responsible for the
efficacy of RPW-24 since others have shown that C. elegans
immune effectors likely function redundantly to defend against P.
aeruginosa infection [8]. The finding that putative immune effectors
are robustly induced by RPW-24 during bacterial infection
provides a potential explanation why this compound provides
protection against P. aeruginosa-mediated killing.
Immunostimulatory Activity of RPW-24 Is Required for Its
Efficacy and Is Partially Dependent on the p38 MAP
Kinase Signaling Cassette
Because RPW-24 caused the induction of genes normally
upregulated during bacterial infection, we reasoned that C. elegans
immune gene activation by RPW-24 is important for its anti-
infective activity and depends on conserved defense response
pathways. Previous studies have identified a requirement for three
C. elegans signaling pathways in the defense against P. aeruginosa
infection: the p38 MAP kinase signaling cassette [10], the G-
protein coupled receptor FSHR-1 [16], and the bZIP transcription
factor ZIP-2 [17]. Using loss-of-function mutants, we asked
whether the activity of any of these pathways is required for the
efficacy of RPW-24 in treating C. elegans infected with P. aeruginosa.
Indeed, we found that the magnitude of RPW-24-mediated
lifespan prolongation of pmk-1(km25) null mutants infected with P.
aeruginosa was significantly attenuated compared to the lifespan
extension observed in compound-treated wild-type animals
(Figure 3) (P,0.001 for the difference in the lifespan prolongation
between pmk-1(km25) and wild-type animals in two biological
replicates). In contrast to pmk-1(km25) mutants, fshr-1(ok778) loss-
of-function mutants demonstrated significant lifespan extension by
RPW-24 compared to pmk-1(km25) animals, despite the fact that
fshr-1(ok778) animals are also hypersusceptible to P. aeruginosa
infection (Figure 3) (P,0.001 for the difference in the lifespan
prolongation between pmk-1(km25) and fshr-1(ok778) in two
biological replicates). Likewise, the lifespan of zip-2(tm4067)
animals infected with P. aeruginosa was also significantly prolonged
by RPW-24, and to a greater degree than pmk-1(km25) (P,0.01 for
the difference in two biological replicates). These data demonstrate
that the activity of PMK-1, more so than FSHR-1 or ZIP-2, is
important for RPW-24 to extend the lifespan of nematodes
infected with P. aeruginosa. Morever, the observed reduction in the
ability of RPW-24 to extend the lifespan of pmk-1(km25) animals is
not likely to be secondary to decreased overall fitness of
immunocompromised animals infected with a bacterial pathogen
because RPW-24 prolongs the lifespan of fshr-1(ok778) animals, a
strain that is also markedly hypersusceptible to P. aeruginosa
infection (Figure 3).
The p38 MAP kinase PMK-1 functions as part of a conserved
signaling cassette to regulate host innate immune responses, which
involves upstream activation by the MAP kinase kinase SEK-1, the
MAP kinase kinase kinase NSY-1 and the Toll-Interleukin-1
receptor TIR-1. We tested the ability of RPW-24 to extend the
lifespan of nematodes with mutations in each of these genes: sek-
1(km4), nsy-1(ag3), and tir-1(qd4). As with the pmk-1(km25) mutants,
Figure 2. RPW-24 induces the transcription of putative immune
effectors in C. elegans. (A) A scatter plot compares gene expression
levels of all 22,250 sequences on the Affymetrix GeneChip in wild-type
C. elegans exposed to RPW-24 versus DMSO. Black dots highlight the
269 genes that were induced and the 62 that were repressed at least
three-fold (P,0.025). Gray dots are genes whose expression levels did
not significantly change in this study. The location on the scatter plot of
the ten putative immune effectors whose expression was studied
further by qRT-PCR are indicated and highlighted with red dots. Genes
that fall on the black line are expressed at equal levels in both
conditions. AU=arbitrary units. (B) Venn diagram gives the overlap of
the C. elegans genes induced three-fold or greater by RPW-24 (P,0.025)
in the microarray analysis (this study) with the genes upregulated
during P. aeruginosa infection (greater than 2-fold, P,0.01) [8].
P,2.7610
216 for the degree of overlap between these datasets versus
the amount expected by chance alone. (C) Shown are qRT-PCR data of
ten putative C. elegans immune effectors in wild-type animals infected
with P. aeruginosa for eight hours and exposed to either 70 mM RPW-24
or DMSO, each plotted versus expression of the indicated genes in C.
elegans exposed to E. coli OP50 and DMSO. The data are the average of
two biological replicates each normalized to a control gene with error
bars representing SEM. *P,0.05, **P=0.06 and ***P=0.08 for the
comparison of fold change of the indicated gene in P. aeruginosa-
infected animals exposed to RPW-24 versus DMSO.
doi:10.1371/journal.pgen.1002733.g002
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each of these mutant strains compared to the wild-type control
(Figure 3), suggestive of a role for the entire TIR-1/NSY-1/SEK-
1/PMK-1 signaling cassette in the activation of defense responses
following exposure to RPW-24.
The infection assays described above show that the p38 MAP
kinase pathway is required for RPW-24 to prolong the lifespan of
C. elegans infected with P. aeruginosa, suggesting that RPW-24
induces the expression of immune effectors regulated by this
cascade. Previous work has shown that PMK-1 coordinates the
transcription of CUB-like genes, ShK toxins and C-type lectins,
gene classes which are also induced by RPW-24 [8]. Indeed, we
found that 14 of the 86 genes whose basal expression depends on
PMK-1 [8] were induced by exposure to RPW-24, which is 14.6
fold more than expected by chance alone (P=0.002)(Table S1).
To test whether RPW-24 activates immune effectors in a PMK-1-
dependent manner, we used qRT-PCR to determine the induction
levels of six putative immune effectors in pmk-1(km25) null mutants
exposed to DMSO and RPW-24 in the absence of pathogen.
Wild-type worms were used as the control. The set of six putative
immune effectors (F35E12.5, F08G5.6, clec-67, C32H11.1, F49F1.6
and mtl-1) were chosen from the panel of ten genes described
above on the criterion that they were robustly upregulated by
RPW-24 (Figure 2A, Figure S3). Figure 4A shows that PMK-1
affects the basal expression levels of the RPW-24-induced genes
F35E12.5, F08G5.6, clec-67 and F49F1.6 (defined as the relative
expression of the gene in pmk-1(km25) mutants compared to its
expression in wild-type animals)(Figure 4A). PMK-1 is also
required for the RPW-24-mediated induction of clec-67 and
C32H11.1 (defined as the fold difference in gene expression in the
presence and absence of RPW-24 in wild-type or pmk-1(km25)
mutant animals), and perhaps F49F1.6 and mtl-1, although the
differences in induction of these later two genes did not reach
statistical significance (Figure 4B). Importantly, the absolute
expression levels of all six of these genes following RPW-24
exposure were significantly lower in pmk-1(km25) animals than
wild-type controls (Figure 4A). Taken together with the P.
aeruginosa infection assays in pmk-1(km25) mutants (Figure 3), these
data suggest that PMK-1-dependent immune effectors mediate
part of the protective effect of RPW-24 in P. aeruginosa-infected C.
elegans.
RNAi Screen Reveals Role for the Transcription Factor
ATF-7 in the Regulation of the RPW-24–Induced Immune
Response
The phenotypic and genetic data presented above show that the
p38 MAP kinase pathway is important for the RPW-24-induced
modulation of C. elegans immune responses during P. aeruginosa
infection. As described above, we found that 70 mM RPW-24
caused a striking increase in GFP production in the
F35E12.5::GFP transcriptional reporter (Figure 1B). We thus
reasoned that an RNAi screen could be used to find downstream
regulator(s) of the RPW-24-induced immune response by identi-
fying the genetic dependence of F35E12.5::GFP activation.
The basal regulation of F35E12.5 requires PMK-1, but its
induction by RPW-24 occurs in a PMK-1-independent manner
(Figure 4A and 4B). We therefore anticipated that a reverse
genetic RNAi screen aimed at identifying transcription factors
required for the RPW-24-mediated induction of F35E12.5::GFP
would identify genetic regulators that act either downstream of or
in parallel to the PMK-1 pathway. We used a feeding RNAi
library containing bacterial clones that produce double stranded
RNA (dsRNA) designed to individually knockdown the expression
of 393 transcription factors in C. elegans, corresponding to 30–50%
of the transcription factors in the C. elegans genome [18] and
screened for RNAi clones that abrogated the RPW-24-mediated
induction of F35E12.5::GFP. Among 393 screened, we found that
a single clone, corresponding to the transcription factor ATF-7,
caused a striking reduction of F35E12.5::GFP expression when
nematodes were either growing on their normal laboratory food
source (E. coli OP50) or infected with P. aeruginosa (Figure 5A).
ATF-7 was previously shown to function downstream of PMK-1 in
the regulation of immune response genes during P. aeruginosa
infection [12].
qRT-PCR analysis confirmed that the reduction of
F35E12.5::GFP expression was due to the knockdown of ATF-7
and not the consequence of non-specific transgene silencing.
Specifically, the absolute level F35E12.5 expression following
RPW-24 exposure was markedly reduced in two atf-7(lof) mutants
[atf-7(qd137) and atf-7(qd22 qd130) [12]] compared to the control
strain (Figure 5B), as were the levels of three other putative
immune effectors (F08G5.6, clec-67 and C32H11.1). Moreover, the
basal levels of F35E12.5, F08G5.6 and clec-67 were reduced to a
similar degree in the atf-7(lof) mutants and the pmk-1(km25)
animals, consistent with the previously described role for PMK-1
Figure 3. Full efficacy of RPW-24 in prolonging the lifespan of
C. elegans infected with P. aeruginosa requires the p38 MAP
kinase signaling cassette. P. aeruginosa infection assays of C. elegans
wild-type and mutant animals exposed to 70 mM RPW-24 compared to
DMSO. Data at each time point are the average of three plates per
strain, each with approximately 50 animals per plate (sample sizes are
given in Table S2). Data are representative of two independent
experiments.
doi:10.1371/journal.pgen.1002733.g003
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Figure 4A and Figure 5B) [12]. Interestingly, we found that ATF-7
was also required for the full induction of five of six putative
immune effectors (F35E12.5, F08G5.6, clec-67, C32H11.1, and
Figure 4. The expression levels of RPW-24–induced putative
immune effectors are reduced in pmk-1(km25) mutants com-
pared to wild-type animals. Six putative C. elegans immune effectors
were analyzed by qRT-PCR in wild-type and pmk-1(km25) feeding on E.
coli and exposed to either 70 mM RPW-24 or DMSO for 16 hours. Data
are the average of two biological replicates each normalized to a
control gene with error bars representing SEM. In (A), the data are
relative to the average expression of the indicated gene in wild-type C.
elegans exposed to DMSO. In (B), the fold change of the indicated gene
above its expression in C. elegans exposed to DMSO is compared in
wild-type and pmk-1(km25) mutant animals. *P,0.01, **P=0.06,
***P=0.09 for the comparison in (A) of relative expression levels in
wild-type versus pmk-1(km25) animals, each exposed to RPW-24 and in
(B) for the fold change in wild-type versus pmk-1(km25) mutant animals.
doi:10.1371/journal.pgen.1002733.g004
Figure 5. The C. elegans transcription factor ATF-7 regulates
immune gene induction by RPW-24. (A) Fluorescence microscopy
images of C. elegans acIs101 animals, which express a F35E12.5::GFP
transgene, exposed to the normal nematode food source E. coli OP50 or
P. aeruginosa in the presence of DMSO or 70 mM RPW-24 for 16 hours at
25uC. C. elegans acIs101 animals were raised on L4440 RNAi control
An Immunostimulatory Small Molecule in C. elegans
PLoS Genetics | www.plosgenetics.org 6 June 2012 | Volume 8 | Issue 6 | e1002733F49F1.6)(Figure 5C), including two genes (F35E12.5 and F08G5.6)
that were induced by RPW-24 independently of PMK-1
(Figure 4B).
To determine if the activity of ATF-7 is important for the
efficacy of RPW-24, we tested the ability of RPW-24 to prolong
the lifespan of atf-7(lof) mutants exposed to P. aeruginosa. The
magnitude of lifespan extension conferred by RPW-24 was
reduced in both the atf-7(qd137) and the atf-7(qd22 qd130)(Figure
S4A and S4B, respectively) mutants compared to the control
strain. We therefore conclude that RPW-24 stimulates the C.
elegans immune response genes in a manner that involves both the
p38 MAP kinase cassette PMK-1 and the conserved transcription
factor ATF-7, consistent with the placement of ATF-7 down-
stream of PMK-1 [12]. Expression analysis of RPW-24-induced
genes (Figure 5C) suggests that in addition to functioning
downstream of PMK-1, ATF-7 receives inputs from a PMK-1
independent pathway to coordinate the induction of putative
immune effectors (such as F35E12.5 and F08G5.6) and the RPW-
24-mediated resistance to P. aeruginosa infection. This conclusion is
based on the finding that the RPW-24-mediated activation of
F35E12.5 and F08G5.6 is PMK-1 independent (as opposed to their
basal level of expression), but is at least partially dependent on
ATF-7 (compare Figure 4B with Figure 5C). That is, the basal
levels of expression of F35E12.5 and F08G5.6 are both PMK-1
and ATF-7 dependent, whereas the fold induction of these genes
following RPW-24 is not affected in the pmk-1(km25) mutant, but is
reduced by at least half in the atf-7(lof) mutants. The biological
significance of this PMK-1-independent transcriptional activator is
not known.
It is also interesting to note that RPW-24 exhibited an
attenuated, but significant (P,0.001) and reproducible ability to
rescue the atf-7(lof) mutants. Therefore, the anti-infective activity
of RPW-24 may involve another immune signaling pathway,
independent of both the p38 MAP kinase pathway and ATF-7.
This conclusion is consistent with the observation that RPW-24
also modestly, but significantly (P,0.001), extends the lifespan of
pmk-1(km25), sek-1(km4), nsy-1(ag3), and tir-1(qd4) mutant animals
infected with P. aeruginosa (Figure 3), and the fact that the induction
of F35E12.5 and F08G5.6 is not completely abrogated in the atf-
7(lof) mutants. An alternate explanation is that RPW-24 affects
virulence factor production by P. aeruginosa or exerts a subtle effect
on growth of the pathogen.
RPW-24 Is Toxic to C. elegans
In addition to inducing a preponderance of genes involved in
the transcriptional response to pathogenic bacteria, RPW-24
caused the upregulation of genes involved in the detoxification of
small molecules (Table S1). The microarray analysis revealed that
58 of the 269 genes activated 3 fold or more and 31 of the 57 genes
activated 50 fold or more were UDP-glucuronosyltransferases
(UDPs), cytochrome P450s (CYPs), glutathione-s-transferases
(GSTs) or short-chain dehydrogenases (SDRs). These gene classes
play integral roles in the Phase I and II detoxification of both
endobiotic and xenobiotic toxins in both nematodes and mammals
[19,20]. Indeed, seven of ten CYPs, two of three UDPs, one of
four GSTs, three of three carboxylesterases, and three of six C-
type lectins were induced both by RPW-24 and exposure to five
xenobiotic toxins [21]. Taken together, these data suggest that
RPW-24 induces xenobiotic detoxification pathways in C. elegans.
To determine if RPW-24 adversely affects wild-type nematodes
growing in the absence of pathogen, we first used a behavioral
assay designed to study the aversion response of C. elegans to
xenobiotic toxins [22]. The addition of some poisons to the center
of small lawns of non-pathogenic E. coli causes C. elegans animals to
leave the lawn, presumably to minimize toxin exposure. Interest-
ingly, we observed a significant aversion response to 70 mM RPW-
24 (Figure 6A and 6B). After 16 hours, 51% of the nematodes had
left the lawn containing RPW-24, whereas only 7% of animals left
a control lawn (P=0.002; Figure 6B). Next, we conducted a
lifespan assay on nematode growth media supplemented with
either DMSO or varying concentrations of RPW-24 and found
that RPW-24 shortened C. elegans lifespan in a dose-dependent
manner (Figure 6C), with 70 mM RPW-24 resulting in a 24%
reduction in median lifespan. Interestingly, we observed lifespan
shortening only at compound concentrations that rescued C. elegans
from P. aeruginosa infection [7, 35 and 70 mM, but not 0.7 mM]. We
also found that 70 mM RPW-24 slowed the development of
animals when they were exposed at the first larval stage
(L1)(Figure 6D).
In C. elegans, oxidative stress is a potent inducer of phase II
detoxification genes. Moreover, the p38 MAP kinase PMK-1
regulates the cellular response to oxidative and arsenite stress, but
through the transcription factor SKN-1, not ATF-7 [12,23–25].
We therefore wondered whether RPW-24 might confer protection
against arsenite stress. We found, however, that 70 mM RPW-24
did not protect nematodes exposed to 5 mM sodium arsenite for
16 hours at 20uC (Figure S5). In fact, the toxicity of RPW-24 and
sodium arsenite were synergistic in this assay, resulting in nearly
100% mortality of wild-type nematodes exposed to both
compounds (Figure S5).
While RPW-24 confers a survival advantage for nematodes
infected with pathogenic bacteria, these data demonstrate that it is
toxic to C. elegans growing under standard laboratory conditions.
Whether this toxicity is a consequence of direct effects of the
compound on C. elegans or hyper-activation of the immune system
by RPW-24 is unknown.
Discussion
We hypothesized that a C. elegans-based screen for novel anti-
infectives would identify small molecules that act by stimulating
the host immune response. Four lines of evidence allow us to
conclude that RPW-24 protects C. elegans from bacterial infection
by inducing the production of putative immune effectors via an
evolutionarily conserved immune pathway. First, RPW-24 confers
a survival advantage for nematodes infected with the Gram-
positive bacteria E. faecalis and the Gram-negative bacteria P.
aeruginosa at doses that do not inhibit in vitro growth of these
pathogens. Second, whole genome microarray analysis demon-
strates that RPW-24 induces a transcriptional response in C. elegans
in the absence of pathogen exposure. We observed that 26% of the
bacteria or an RNAi feeder strain designed to knockdown the
expression of atf-7. Green is GFP expression. (B and C) Six putative C.
elegans immune effectors were analyzed by qRT-PCR in wild-type, atf-
7(qd137) and atf-7(qd22 qd130) animals feeding on E. coli and exposed
to either 70 mM RPW-24 or DMSO for 16 hours. Data are presented as
the average of two biological replicates each normalized to a control
gene with error bars representing SEM. In (A), the data are relative to
the average expression of the indicated gene in wild-type C. elegans
exposed to DMSO. In (B), the fold change of the indicated gene above
its expression in C. elegans exposed to DMSO is compared in wild-type,
atf-7(qd137) and atf-7(qd22 qd130) animals. An N2-derived strain
carrying the acIs219 transgene was used as the control strain because
this transgene is also present in the atf-7(lof) strains [12]. *P,0.05,
**P=0.08, ***P=0.09 for the comparison in (A) of the relative
expression levels of both atf-7(lof) strains versus control animals, each
exposed to RPW-24, and in (B) for the fold change in wild-type versus
both atf-7(lof) mutants.
doi:10.1371/journal.pgen.1002733.g005
An Immunostimulatory Small Molecule in C. elegans
PLoS Genetics | www.plosgenetics.org 7 June 2012 | Volume 8 | Issue 6 | e1002733genes induced 3-fold or greater are also induced by infection with
P. aeruginosa. Moreover, we showed that the RPW-24-mediated
induction of several putative immune effectors is enhanced in the
context of P. aeruginosa infection. Third, using C. elegans animals
deficient in immune pathway signaling in pathogenesis assays and
gene expression analyses, we demonstrated that the TIR-1/NSY-
1/SEK-1/PMK-1 cascade in C. elegans is required for RPW-24 to
exert its full effect. Lastly, an RNAi screen indicated that the
transcription factor ATF-7 controls the RPW-24-mediated induc-
tion of a putative immune effector gene. The ability of RPW-24 to
promote survival of P. aeruginosa-infected nematodes is partially
dependent on this transcription factor. ATF-7 has been shown to
function downstream of the MAPK PMK-1 to activate the
expression of immune effectors [12]. Here we show that ATF-7
also activates the expression of genes independently of the PMK-1
p38 MAPK pathway. In summary, these data strongly suggest that
immune gene activation by RPW-24 is required for its protective
effects. While it is theoretically possible that RPW-24 confers
protection for C. elegans by also inhibiting virulence factor
production in both E. faecalis and P. aeruginosa, we feel this is less
likely given that clear effects of RPW-24 on the nematode and the
evolutionary diversity between these bacterial pathogens.
An unexpected observation in our transcriptome profiling
analysis was that RPW-24 caused the dramatic induction of genes
involved in the detoxification of small molecules, including UDP-
glucuronosyltransferases (UGTs), cytochrome P450s (CYPs),
glutathione-s-transferases (GSTs) and short-chain dehydrogenases
(SDRs). In mammals, these gene classes act together to detoxify
xenobiotic small molecules via two successive reactions [19]. Phase
I reactions involve the addition of chemically reactive functional
groups to the toxins and are predominantly mediated by CYPs
and SDRs. In Phase II, UGTs and GSTs add side groups that
increase the solubility of small toxic molecules, which aides in their
excretion. These mediators of detoxification are highly conserved
throughout evolution and are present in C. elegans [20,26,27].
Their marked induction by RPW-24 suggests that this compound
may be recognized as a toxin. Consistent with this hypothesis,
RPW-24 caused a strong behavioral avoidance phenotype,
shortened nematode lifespan, and delayed the development of
nematodes growing on non-pathogenic bacteria.
We have identified a low molecular weight molecule that can
potently activate the innate immune response of C. elegans. The
target of this compound is not known, nor are the mechanisms that
act upstream of the p38 MAP kinase cassette to trigger the RPW-
24-mediated immune activation in C. elegans. Indeed, it also
unclear how any of the C. elegans immune pathways, including the
p38 MAP kinase cassette, are activated during bacterial infection.
Recently, several investigators have shown that the nematode
monitors the integrity of cellular processes as a means to detect
pathogen invasion, and to trigger defense responses and behavioral
avoidance phenotypes. McEwan et al. [28] and Dunbar et al. [29]
each found that the inhibition of translation by a bacterial toxin
induced a protective immune response in C. elegans that was
dependent on the p38 MAP kinase and ZIP-2 pathways. Similarly,
Melo et al. showed that disruption of core cellular processes, such
as translation, mitochondrial respiration and proteasome function,
by bacterial toxins induced a behavioral avoidance phenotype
[22]. Thus, it is possible that the toxic effects of RPW-24 trigger
immune response pathways and a behavioral aversion response in
an analogous manner. Alternatively, RPW-24 itself could directly
activate immune pathways in C. elegans.
In this study, we have demonstrated the utility of using small
molecules in conjunction with classical epistasis analysis and RNAi
screens to dissect immune signaling pathways in C. elegans.W e
therefore hypothesize that RPW-24 can be used as a tool in
additional genetic analyses both to identify the target(s) of this
small molecule and to determine mechanism by which the p38
MAP kinase pathway is activated by RPW-24, which may offer
insights into how C. elegans detects bacterial pathogens.
Figure 6. RPW-24 is toxic to C. elegans. (A) Wild-type C. elegans
leave a lawn of E. coli containing 70 mM RPW-24 more so than DMSO
after 16 hours of exposure. (B) The average percentage of wild-type C.
elegans that were off a lawn of E. coli supplemented with either DMSO
or 70 mM RPW-24 after 16 hours of exposure from three plates per
condition [as in (A)] is presented with error bars representing SEM.
P=0.002 for the comparison of the two conditions. (C) RPW-24 shortens
the lifespan of wild-type C. elegans in a dose-dependent manner. Data
at each time point are the average of three plates per strain, each with
approximately 50 animals per plate (sample sizes are given in Table S2).
(D) RPW-24 slows development of wild-type C. elegans. Developmental
stage was accessed in 50 animals per treatment group and presented as
the percentage of the population that was at the indicated
development stage after 65 hours of incubation at 20uC.
doi:10.1371/journal.pgen.1002733.g006
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bial-resistant pathogens are one of the three greatest threats to
human health. Exacerbating this problem is the striking absence of
novel antibiotics in the development pipeline. In 2008, there were
only 16 antimicrobial compounds in late stage clinical trials and
only one of these agents had a novel mechanism of action [30].
Furthermore, all of these agents target some aspect of bacterial
replication or metabolism. Indeed, it has been suggested that the
obvious bacterial targets amenable for antimicrobial drug design
have been exhausted [31]. Identifying host-acting small molecules
that modulate innate immune responses is a promising approach
to identify novel antimicrobial therapies [32]. In theory, such
agents should place minimal selection pressure on bacteria to
acquire resistance determinants and could have broad-spectrum
antimicrobial activity. Agonists of the mammalian Toll-like and
NOD-like receptors are among the most promising compounds
that are being explored for this purpose [32,33]. We propose that
C. elegans-based compound screening assays can be used to mine
large chemical libraries for additional small molecule anti-
infectives that act by stimulating host immune defenses. Whether
or not these host-acting small molecules will be effective for the
treatment of bacterial infections in mammals, genetic dissection of
the C. elegans signaling pathways activated by such compounds may
suggest strategies for the development of new classes of antimi-
crobial therapies.
Materials and Methods
C. elegans Strains
C. elegans were maintained and propagated on E. coli OP50 as
described [34]. The C. elegans strains used in this study were: N2
Bristol [34], pmk-1(km25) [10], sek-1(km4) [10], nsy-1(ag3) [10], tir-
1(qd4) [11], atf-7(qd137) [12], atf-7(qd22 qd130) [12], fshr-1(ok778)
[16], zip-2(tm4067) [17] glp-4(bn-2) [35], AU78 [agIs219
(pT24B8.5::GFP::unc-54-39UTR pttx-3::GFP::unc-54-39utr)] [11]
and AY101 [acIs101[pDB09.1(pF35E12.5::GFP); pRF4(rol-
6(su1006))] [13].
C. elegans Bacterial Infection and Other Assays
Slow-killing P. aeruginosa solid media infection assays were
performed as previously described [15] with some modifications. A
single colony of P. aeruginosa PA14 was innoculated into 3-mL of
Luria-Bertani (LB) media and allowed to incubate at 37uC for 14
to 15 hours. 10 mL of this culture was added to 35-mm tissue
culture plates containing 4 mL of slow kill agar supplemented with
1% DMSO and the indicated conentration of RPW-24. Others
have shown that this concentration of DMSO has little effect on
growth or development of C. elegans [36,37]. Plates were incubated
for 24 hours at 37uC and 24 hours at 25uC. C. elegans lifespan
assays were conducted on nematode growth media (NGM)
supplemented with the indicated concentraion of RPW-24 and
seeded with OP50. The sensitivity of RPW-24-treated wild-type
animals to oxidative stress was determined using 5 mM sodium
arsenite following a previously described protocol [12]. For the
infection, lifespan and sodium arsenite assays, 0.1 mg/mL 5-
fluorodeoxyuridine (FUDR) was added to the media 1 to 2 hours
before the start of the assay to prevent progeny from hatching.
Approximately 50 L4 staged nematodes were picked to each of
three or four assay plates per experimental condition. Animals
were scored as live or dead on a daily basis by gently touching
them with a platinum wire. Worms that crawled onto the wall of
the tissue culture plate were eliminated from the analysis. The P.
aeruginosa killing assays were conducted at 25uC. The lifespan and
sodium arsenite assays were performed at 20uC. The sample sizes
for each of these experiments are given in Table S2. For the
experiments with the atf-7(lof) mutants, we used an N2-derived
strain carrying the acIs219 transgene (AU78) as the control strain
because this transgene is also present in the atf-7 mutant strains
[12]. The C. elegans liquid media infection assay used to screen the
31 compounds for those with activity against P. aeruginosa-infected
nematodes was developed in our laboratory and was conducted in
either 384 or 96 well plates using glp-4(bn-2) animals (Kirienko,
NV and Ausubel FM, unpublished data). Growth of P. aeruginosa in
the presence of RPW-24 was determined by inoculating 1.0610
4
bacteria in liquid slow-kill media containing either 70 mM RPW-
24 or DMSO and allowing the culture to grow at 37uC in a roller
drum. At the indicated time points, 10 mL of the culture was
removed and CFUs were determined by plating serial dilutions.
The propensity of wild-type C. elegans to leave a lawn of bacteria
supplemented with RPW-24 was assayed using a previously
described protocol [22]. Briefly, 6-well tissue culture plates
containing NGM were seeded with concentrated E. coli OP50.
70 mM RPW-24 or an equal volume of DMSO was added to the
center of the E. coli lawn and allowed to dry. 70 to 90 young L4
animals were added to the center of the lawns and animals were
scored as either on or off the lawn after 16 hours incubation at
room temperature. To determine if RPW-24 slowed the develop-
ment of wild-type animals, 70 mM RPW-24 or DMSO was added
to NGM plates and seeded with OP50. L1 staged animals,
synchronized by hypochlorite treatment, were added to these
plates and allowed to incubate at 20uC for 65 hours. Develop-
mental stages of 50 animals per treatment group were determined
by microscopic examination of the gonad.
C. elegans Microarray Analysis
N2 animals were synchronized by hypochlorite treatment.
Arrested L1s were plated on 10 cm NGM plates seeded with E. coli
OP50 and grown at 20uC until the late L4 larval stage. Animals
were incubated for 15 hours at 15uC in 2 mL of liquid S-basal
complete medium [38] containing 70 mM RPW-24 or DMSO and
supplemented with E. coli OP50. The final concentration of
DMSO in both samples was 1%. RNA was extracted from three
biological replicates using TRI Reagent (Molecular Research
Center) according to the manufacturer’s instructions and purified
using an RNeasy column (Qiagen). RNA samples were prepared
and hybridized to Affymetrix full-genome GeneChips for C. elegans
at the Harvard Medical School Biopolymer Facility (Boston, MA)
following previously described protocols [5,8] and instructions
from Affymetrix. Data were analyzed using GenePattern version
2.0 software using GC-RMA and quantile normalization [39].
Conditions were compared using GenePattern to determine the
fold change between conditions for each probe set and to generate
a P value using a modified t-test. Probe sets were considered
differentially expressed if the fold change was 3-fold or greater
(P,0.025).
Quantitative RT–PCR (qRT–PCR) Analyses
Animals of the indicated genotype were treated and RNA was
extracted as described for the microarray analysis. For the
experiments with the atf-7(lof) mutants, we used strain AU78 as
as the control strain [12]. For gene expression analysis of
nematodes on solid media, 70 mM RPW-24 or DMSO was added
to 20 mL nematode growth media in 10 cm petri dishes seeded
with E. coli OP50. For qRT-PCR studies of nematodes infected
with P. aeruginosa, 20 mL of slow killing media was added to 10 cm
petri dishes containing either DMSO or 70 mM RPW-24. Plates
were seeded with either 250 mLo fE. coli OP50 or 50 mL P.
aeruginosa diluted in 200 mL LB, each from overnight cultures. The
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Old L4/young adult animals were added to the assay plates and
incubated at 25uC for eight hours. RNA was reverse transcribed to
cDNA using the Retroscript kit (Ambion). cDNA was analyzed by
qRT-PCR using a CFX1000 machine (Bio-Rad) and previously
published primers [8]. All values were normalized against the
control gene snb-1, which has been used previously in qRT-PCR
studies of C. elegans innate immunity [5,8,9,12,40]. Analysis of the
microarray expression data revealed that the expression of snb-1
did not vary under the conditions tested in the experiment. Fold
change was calculated using the Pfaffl method [41].
Feeding RNAi Screen
The RNAi screen of 393 transcription factors was conducted
using RNAi clones from the Ahringer and Vidal RNAi libraries
and an established protocol [42]. The RNAi clone for atf-7 was
developed by Shivers et al [12]. Briefly, overnight cultures of
feeding RNAi clones were added to each well of a 96-well RNAi
plate and allowed to grow at room temperature overnight. 40–60
L1 staged acIs101 animals, which express a F35E12.5::GFP
transgene, were added to each well and allowed to grow for two
days at 20uC until they were at the L4 or young adult stage.
Animals were then washed from the RNAi plates into S-basal
complete media [38] containing 70 mM RPW-24. All experiments
with feeding RNAi used a gfp RNAi as the negative control, which
resulted in no visible GFP expression in acIs101 transgenic
animals. acIs101 animals treated with the empty vector L4440
and exposed to 70 mM RPW-24 was used as the positive control.
Animals were scored for GFP expression following photograph of
each well using an Image Xpress Micro microscope (Molecular
Devices Corporation, Sunnyvale, CA).
Microscopy
Nematodes were mounted onto agar pads, paralyzed with
10 mM levamisole (Sigma) and photographed using a Zeiss AXIO
Imager Z1 microscope with a Zeiss AxioCam HRm camera and
Axiovision 4.6 (Zeiss) software.
Statistical Analyses
Differences in survival of C. elegans animals infected with P.
aeruginosa on slow-killing assay plates were determined with the log-
rank test. To determine if the increase in survival conferred by
RPW-24 treatment was different in one population compared to
another [for example, in wild-type versus pmk-1(km25) animals],
we examined the difference in the effect of RPW-24 treatment on
the hazard in each group using a Cox proportional hazard model
(Stata11, Stata, College Station, TX). Fold changes in the qRT-
PCR analyses and the differences in survival in the arsenite assays
were compared using unpaired, two-tailed student t-tests. When
comparing microarray datasets, the overlap expected by chance
alone was determined in 50 groups of randomly selected C. elegans
genes using Regulatory Sequence Analysis Tools (http://rsat.ulb.
ac.be/rsat/), a technique that has been used for similar analyses
[43]. P values were determined using chi-square tests.
Accession Numbers
Accession numbers for the genes and gene products mentioned
in this paper are given for Wormbase, a publicly available
database that can be accessed at http://www.wormbase.org.
These accession numbers are pmk-1 (B0218.3), nsy-1 (F59A6.1),
sek-1 (R03G5.2), atf-7 (C07G2.2), zip-2 (K02F3.4), fshr-1 (C50H2.1),
skn-1 (T19E7.2), C32H11.1, F35E12.5, F08G5.6, C29F3.7,
K08D8.5, F49F1.6, C14C6.5, lys-7 (C02A12.4), clec-67 (F56D6.2)
and mtl-1 (K11G9.6). The microarray dataset can be downloaded
from the National Center for Biotechnology Gene Expression
Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo). The acces-
sion number for these data is GSE37266.
Supporting Information
Figure S1 The compound structures of the anti-infective small
molecules presented in Table 1.
(EPS)
Figure S2 RPW-24 reduces the burden of P. aeruginosa in the C.
elegans intestine. Wild-type nematodes exposed to either DMSO or
70 mM RPW-24 were photographed 40 hours after infection with
P. aeruginosa. At 40 hours after infection, greater than 95% of
animals are still alive in both treatment groups (Figure 1C). Images
from the proximal (top) and mid (bottom) portions of the intestine
are presented. Arrowheads outline the intestinal lumen and the
arrow points to the pharyngeal grinder. Individual P. aeruginosa can
be seen within the C. elegans intestine in the picture on the top left.
The scale bar equals 10 mm.
(EPS)
Figure S3 RPW-24 induces the transcription of putative
immune effectors. 10 putative immune effectors that were induced
in the microarray analysis (Figure 2A) were studied by qRT-PCR
in RPW-24 and DMSO-exposed animals on solid and in liquid
media. The fold change of the indicated genes in animals exposed
to RPW-24 versus expression in DMSO-exposed animals in the
transcriptome profiling analysis is indicated with gray bars. qRT-
PCR data are plotted versus expression of the indicated genes in C.
elegans exposed to DMSO on the indicated media and are
presented as the average of two biological replicates each
normalized to a control gene with error bars representing SEM.
(EPS)
Figure S4 The full efficacy of RPW-24 requires the C. elegans
transcription factor ATF-7. P. aeruginosa infection assay of wild-type
C. elegans compared to atf-7(qd137) (A) and atf-7(qd22 qd130)
mutant animals (B) exposed to 70 mM RPW-24 and DMSO. Data
at each time point are the average of three plates per strain, each
with approximately 50 animals per plate (sample sizes are given in
Table S2). The lifespan extension conferred by RPW-24 in wild-
type animals was significantly greater than that observed in atf-
7(qd137) and atf-7(qd22 qd130) animals (P,0.001 for both
comparisons). Data are representative of two independent
experiments. An N2-derived strain carrying the acIs219 transgene
was used as the control strain because this transgene is also present
in the atf-7(qd137) mutant [12].
(EPS)
Figure S5 RPW-24 does not cause resistance to arsenite.
Animals were treated with 5 mM sodium arsenite and 70 mM
RPW-24 (24) or DMSO (D) for 18 hours. Shown is the average
survival of animals on three plates per condition, each with
approximately 50 animals per plate (sample sizes are given in
Table S2). The error bars are SEM. P,0.01 for the comparison in
survival.
(EPS)
Table S1 Differentially expressed genes following RPW-24
treatment identified in a genome-wide transcriptional profiling
experiment. Presented are the lists of Affymetrix probe sets, the
corresponding gene names, the fold change and the P value for all
probe sets whose expression changed more than three-fold
(P,0.025) in wild-type nematodes exposed to RPW-24 versus
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worksheet.
(XLSX)
Table S2 Sample sizes for the infection assays, the lifespan assay
and the arsenite assay. Sample sizes do not include censored animals.
(XLSX)
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